family, on the other are the increased perinatal mortality and morbidity as well as a much greater load for the mother after delivery.
Types
Multiple pregnancy follows either the division of an oocyte fertilised by one sperm into two separate bodies (identical or monozygotic twins) or the fertilisation of more than one egg by separate sperm (non-identical or dizygotic twins). In higher multiple pregnancies than twins a combination of these two mechanisms happens.
In uniovular twins division into two separate bodies was thought to occur only at a very early stage but it can in fact take place up to several days after fertilisation.
Monovular and binovular twins. 1950 1960 1970 1980 Proportion of maternities resulting in multiple births (England and Wales, 1939-89) . Proportion of maternities resulting in triplet or higher order birth (England and Wales, 1939-89) .
In early pregnancy twin sacs and embryos can be shown by ultrasonography.
Prevalence
The prevalence of twin births in the United Kingdom is one in 105 deliveries, of triplets one in 10 000, and of quadruplets about one in every half a million deliveries. There is a natural variation between races; Japanese women have a lower rate of twins and those from some African countries have a higher rate, up to one in 50 deliveries. Multiple pregnancies also increase with maternal age. These biological variations are due to an increase in the dizygous twinning rates, the capacity of the woman to produce more than one oocyte at the time of ovulation.
The prevalence of multiple pregnancy has been increasing in the United Kingdom in the past decade. For higher multiples than twins the rate doubled from 12 per 100 000 to 29 per 100 000 between 1980 and 1989. Though a part of this is due to the increasing number of mothers over 35, the iatrogenic effect of ovarian stimulation and in vitro fertilisation programmes are also important. Concern about this has led bodies such as the Interim Licensing Authority (soon to be the Human Fertilisation and Embryology Authority) to make recommendations about the maximum number of oocytes or embryos transferred at assisted fertilisation.
Diagnosis
Twin pregnancies used to be diagnosed clinically when the woman reported her symptoms of pregnancy were worse than usual and the abdomen was found to be bigger for the expected gestational dates (after about 24 weeks); sometimes twins were diagnosed for the first time in labour. Often the fetal parts are hard to determine. Now in the United Kingdom most women have an ultrasound scan at 16 t6 18 weeks and so multiple pregnancies are usually diagnosed much sooner. In the Scottish twin survey 70% of multiple pregnancies were diagnosed by ultrasonography before 20 weeks and 95% were diagnosed in the antenatal period. Should a twin pregnancy be diagnosed by ultrasonography the increased incidence of congenital abnormalities should be remembered and a thorough ultrasound examination of each fetus performed at about 20 weeks. Multiple pregnancies have increased risks for both mother and fetuses. Perinatal mortality rates are about four times higher among twins than singletons, being higher among monozygotic twins. Rates are even greater in triplets and quadruplets. About three quarters of the increased mortality is caused by immaturity following preterm delivery, by intrauterine growth retardation, or by some combination of the two. The perinatal mortality rate for the second twin at vaginal deliveries is much higher than that of the first, depending on the skills of the doctor in charge of the delivery. The perinatal mortality rates associated with antepartum haemorrhage, premature rupture of the membranes, and proteinuric hypertension are increased.
Though some of the increased perinatal mortality rate in twins can be reduced by careful delivery, a large component can be helped by good antenatal care. This includes diagnosing the multiple pregnancy early, carefully managing the woman throughout pregnancy, and either postponing early preterm labour and ensuring that it takes place in an appropriate unit with a good neonatal unit. 
ANY QUESTIONS
What is the most up to date method oftreating subungual warts?
The most important aspect of the management of subungual warts is to ensure that the correct diagnosis has been made. Typical morphology of a viral wart may be seen in the periungual area. If there is doubt, however, a biopsy should be performed, if necessary first avulsing the nail to exclude such conditions as in situ or invasive squamous carcinoma or amelanotic malignant melanoma. An x ray examination of the digit should also be performed when subungual exostosis is suspected.
As many periungual warts extend beneath the nail plate treatment with topical keratolytic agents or cryotherapy may not be entirely successful, though these methods should usually be tried first. Intralesional infiltration of bleomycin solution has been used effectively in periungual and subungual warts, particularly those under the distal edge of the nail. Resolution rates of between 70% and 80% have been achieved with no residual scarring.' Care must be taken, however, to avoid inadvertent infiltration of the nail matrix as this can result in permanent nail dystrophy.
For more extensive subungual warts avulsion of the nail will allow blunt dissection or curettage and cautery to be carried out, but as with warts in other sites recurrences are not infrequent after a surgical approach. The reason for this may be the presence of latent human papillomavirus DNA in adjacent clinically and histologically normal skin.2 Carbon dioxide laser vaporisation of periungual warts has proved successful in around 70% of treated cases.3 Postoperative pain and onycholysis may be a problem, and as with other surgical approaches recurrences do occur because of either subtotal clearance of the wart or activation of the latent human papillomavirus DNA in adjacent skin. There is the added worry about potential infectivity of the laser plume, which may contain human papillomavirus DNA.
Early work suggests that induction of contact hypersensitivity with diphenciprone (not yet licensed) may be useful in treating viral warts, but subungual warts are obviously less accessible for application of this substance. Many viral warts resolve spontaneously with no scarring even after several years. Thus the potential side effects of treatment should always be weighed against the disability caused by the wart. Is there any evidence of a carcinogenic effect associated with the filter papers used for coffee making?
During the past decade or so analytical techniques have achieved an extremely high sensitivity. The question about the safety of coffee filters stems from the fact that the presence of substances such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds may be detected in amounts several orders of magnitude lower than those that have been found to have any toxic effect. Coffee filters are made of white paper derived from wood pulp submitted to a bleaching process. If the bleaching process uses chlorine rather than oxygen there is a risk that tiny traces of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related substances will remain in the product. Furthermore, it is likely to be leached out of the filter paper during coffee making. Although 2,3,7,8-tetrachlorodibenzo-p-dioxin is certainly one of the most toxic chemicals known to man, the amounts of it that would be ingested, even by a heavy coffee drinker during a lifetime of drinking filtered coffee, would be negligibly small compared with the lowest cumulative dose that could be expected to give rise to any toxic effect. 2,3,7,8-Tetrachlorodibenzo-p-dioxin is not mutagenic or genotoxic in a way that is relevant to a risk of cancer. In animals it increases the risk of the development of neoplasms of certain kinds by various non-genotoxic mechanisms. None of these would operate with the intake of 2,3,7,8-tetrachlorodibenzo-p-dioxin from filtered coffee.
In the United Kingdom the Committee on Toxicity agreed that an intake of 10 ng/kg body weight per day does not have a carcinogenic effect. The likely maximum daily intake of 2,3,7,8-tetrachlorodibenzo-p-dioxin from coffee made by a filtration process using chlorine bleached filter paper can be calculated to be several orders of magnitude less than this.
So the answer to the question is "No." On the other hand, as chlorine bleaching of wood pulp leads to environmental pollution by dioxins and related substances there is a case to be made for educating the consumer to accept non-white paper products or white paper that has been bleached by processes not using chlorine. -FRANCIS J C ROE, consultant in toxicology, London
